Extra transparency measures for COVID-19 vaccines and therapeutics
EMA published its latest measures in EMA’s drive to maximise the transparency of its regulatory activities on treatments and vaccines for COVID-19.
Two further extra transparency measures for COVID-19 medicines have been actvated.
More on EMA’s transparency measures can be found here.
EMA’s dedicated website on Covid-19 can be accessed here.
